STERIS plc (STE) is likely to grow in the coming quarters, backed by the promising recovery potential in the AST (Applied Sterilization Technologies) segment. The company also benefits from the growing healthcare and pharmaceutical sectors, fueled by an aging population and strategic acquisitions like the BD assets purchase. Strong solvency buoys optimism. Meanwhile, headwinds such as foreign currency risks and macroeconomic challenges raise worry for the stock. In the past year, shares of this Zacks Rank # ...